Abstract
Objectives: To describe the clinical manifestations and outcomes of critically ill children with coronavirus disease-19 (COVID-19) in New York City.
Study design: Retrospective observational study of children 1 month to 21 years admitted March 14 to May 2, 2020, to 9 New York City pediatric intensive care units (PICUs) with severe acute respiratory syndrome coronavirus 2 infection.
Results: Of 70 children admitted to PICUs, median age was 15 (IQR 9, 19) years; 61.4% male; 38.6% Hispanic; 32.9% black; and 74.3% with comorbidities. Fever (72.9%) and cough (71.4%) were the common presenting symptoms. Twelve patients (17%) met severe sepsis criteria; 14 (20%) required vasopressor support; 21 (30%) developed acute respiratory distress syndrome (ARDS); 9 (12.9%) met acute kidney injury criteria; 1 (1.4%) required renal-replacement therapy, and 2 (2.8%) had cardiac arrest. For treatment, 27 (38.6%) patients received hydroxychloroquine; 13 (18.6%) remdesivir; 23 (32.9%) corticosteroids; 3 (4.3%) tocilizumab; and 1 (1.4%) anakinra; no patient was given immunoglobulin or convalescent plasma. Forty-nine (70%) patients required respiratory support: 14 (20.0%) noninvasive mechanical ventilation, 20 (28.6%) invasive mechanical ventilation (IMV), 7 (10%) prone position, 2 (2.8%) inhaled nitric oxide, and 1 (1.4%) extracorporeal membrane oxygenation. Nine (45%) of the 20 patients requiring IMV were extubated by day 14 with median IMV duration of 218 (IQR 79, 310.4) hours. Presence of ARDS was significantly associated with duration of PICU and hospital stay, and lower probability of PICU and hospital discharge at hospital day 14 (P < .05 for all).
Conclusions: Critically ill children with COVID-19 predominantly are adolescents, have comorbidities, and require some form of respiratory support. The presence of ARDS is significantly associated with prolonged PICU and hospital stay.
Keywords: pediatric ARDS; pediatric respiratory failure; pediatric viral sepsis.
【저자키워드】 pediatric ARDS, pediatric respiratory failure, pediatric viral sepsis., 【초록키워드】 COVID-19, Treatment, coronavirus disease, convalescent plasma, Prone position, ARDS, coronavirus, Corticosteroids, therapy, Respiratory failure, Anakinra, Hydroxychloroquine, acute respiratory distress syndrome, mechanical ventilation, Tocilizumab, nitric oxide, pediatric, children, hospital, Infection, Comorbidities, intensive care unit, Remdesivir, Sepsis, Acute kidney injury, outcome, severe acute respiratory syndrome Coronavirus, cough, New York City, observational study, Cardiac arrest, clinical manifestations, Probability, extracorporeal membrane oxygenation, Viral, Critically ill, Coronavirus disease-19, Immunoglobulin, Patient, Inhaled, respiratory, Hispanic, acute respiratory distress, Invasive mechanical ventilation, Respiratory Support, noninvasive, Hospital stay, respiratory distress, clinical manifestation, presenting symptoms, severe sepsis, acute respiratory syndrome, median age, hospital discharge, syndrome, vasopressor support, IMV, significantly, required, median, children with COVID-19, IQR, Presence, 【제목키워드】 New York City, clinical manifestations, clinical, Adolescent, manifestation, Ill,